Takeda Pharmaceutical Company Ltd
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
A Study to Improve the Awareness of Mucopolysaccharidosis Type II in Brazil
- Conditions
- Mucopolysaccharidosis (MPS)
- Interventions
- Other: No Intervention
- First Posted Date
- 2021-12-13
- Last Posted Date
- 2022-05-09
- Lead Sponsor
- Takeda
- Target Recruit Count
- 250
- Registration Number
- NCT05155488
- Locations
- 🇧🇷
Takeda Distribuidora Ltda, São Paulo, Brazil
A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis
- First Posted Date
- 2021-12-10
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Takeda
- Target Recruit Count
- 305
- Registration Number
- NCT05153148
- Locations
- 🇵🇱
Nimbus site #XYZ, Wroclaw, Poland
A Study of TAK-771 in Japanese People With Primary Immunodeficiency Diseases (PID)
- First Posted Date
- 2021-12-09
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Takeda
- Target Recruit Count
- 16
- Registration Number
- NCT05150340
- Locations
- 🇯🇵
Saitama Prefectual Children's Medical Center, Saitama, Japan
🇯🇵Shizuoka Childrens Hospital, Shizuoka, Japan
🇯🇵Nagoya University Hospital, Nagoya, Aichi, Japan
A Study With Lanadelumab in Persons With Hereditary Angioedema (HAE) in Poland
- Conditions
- Hereditary Angioedema (HAE)
- First Posted Date
- 2021-12-07
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Takeda
- Target Recruit Count
- 48
- Registration Number
- NCT05147181
- Locations
- 🇵🇱
Wojewódzki Szpital Specjalistyczny im. Stefana Kardynała Wyszyńskiego, Lublin, Lubelskie, Poland
🇵🇱Szpital Uniwersytecki w Krakowie, Kraków, Małopolskie, Poland
🇵🇱Kliniczny Szpital Wojewódzki nr 1 im. Fryderyka Chopina w Rzeszowie, Rzeszów, Podkarpackie, Poland
A Study of Relative Bioavailability of a New Formulation Compared With the Approved Formulation of rhPTH [1-84] and to Find Out Dose Linearity of the New Formulation in Healthy Adults
- First Posted Date
- 2021-11-30
- Last Posted Date
- 2023-12-15
- Lead Sponsor
- Takeda
- Target Recruit Count
- 96
- Registration Number
- NCT05137730
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
A Study on the Use of Healthcare Resources and Costs of Attention Deficit Hyperactivity Disorder (ADHD) in Adults in England
- Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)
- Interventions
- Other: No intervention
- First Posted Date
- 2021-11-30
- Last Posted Date
- 2022-07-12
- Lead Sponsor
- Takeda
- Target Recruit Count
- 2236
- Registration Number
- NCT05137704
- Locations
- 🇬🇧
IQVIA Ltd, London, United Kingdom
A Study of Maribavir in Japanese People With Cytomegalovirus (CMV) Infection
- First Posted Date
- 2021-11-30
- Last Posted Date
- 2024-07-09
- Lead Sponsor
- Takeda
- Target Recruit Count
- 41
- Registration Number
- NCT05137717
- Locations
- 🇯🇵
Ehime University Hospital, Toon, Ehime, Japan
🇯🇵Kyushu University Hospital, Fukuoka-shi, Fukuoka, Japan
🇯🇵Hokkaido University Hospital, Sapporo, Hokkaido, Japan
A Survey of Darvadstrocel in People with Crohn's Disease
- First Posted Date
- 2021-11-09
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Takeda
- Target Recruit Count
- 275
- Registration Number
- NCT05113095
- Locations
- 🇯🇵
Takeda selected site, Tokyo, Japan
Retrospective Study on Participants With Short Bowel Syndrome and Chronic Intestinal Failure That Underwent Transplantation in Brazil
- Conditions
- Short Bowel Syndrome (SBS)
- First Posted Date
- 2021-11-09
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Takeda
- Target Recruit Count
- 7
- Registration Number
- NCT05113082
- Locations
- 🇧🇷
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo, Brazil
A Study of Azilsartan in Children from 6 to Less Than 16 Years Old with High Blood Pressure
- First Posted Date
- 2021-11-04
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- Takeda
- Target Recruit Count
- 5
- Registration Number
- NCT05107960
- Locations
- 🇯🇵
Takeda selected site, Tokyo, Japan